TrianglePUBLICATIONS · 28292935
Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Mol Cancer Ther
- Publication date
- 2017 May
- First author
- Chan-Penebre E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Chan-Penebre E
- type
- Author
- name
- Armstrong K
- type
- Author
- name
- Drew A
- type
- Author
- name
- Grassian AR
- type
- Author
- name
- Feldman I
- type
- Author
- name
- Knutson SK
- type
- Author
- name
- Kuplast-Barr K
- type
- Author
- name
- Roche M
- type
- Author
- name
- Campbell J
- type
- Author
- name
- Ho P
- type
- Author
- name
- Copeland RA
- type
- Author
- name
- Chesworth R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Chan-Penebre E
- type
- Author
- name
- Armstrong K
- type
- Author
- name
- Drew A
- type
- Author
- name
- Grassian AR
- type
- Author
- name
- Feldman I
- type
- Author
- name
- Knutson SK
- type
- Author
- name
- Kuplast-Barr K
- type
- Author
- name
- Roche M
- type
- Author
- name
- Campbell J
- type
- Author
- name
- Ho P
- type
- Author
- name
- Copeland RA
- type
- Author
- name
- Chesworth R
- type
- Author
- bibliography ids
- nci-bib-91d324e37f5a592b7f32606b
- book metadata
- content sha256
- 4b253c0e9bd1a578b72c08876046d6558a9832677d10184ec444d6b54345c243
- document type
- citation
- dois
- 10.1158/1535-7163.MCT-16-0678
- electronic publication date
- display
- 2017 Mar 14
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28292935
- immutable id
- pubmed:28292935@4b253c0e9bd1a578b72c08876046d6558a9832677d10184ec444d6b54345c243
- journal
- abbreviation
- Mol Cancer Ther
- issn electronic
- 1538-8514
- issn print
- 1535-7163
- issue
- 5
- name
- Molecular cancer therapeutics
- nlm unique id
- 101132535
- pages
- 850-860
- volume
- 16
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28292935
- provenance
- batch id
- 7a1288ac8bb5f9826304
- provider
- NCBI PubMed ESummary
- record sha256
- 4ca2314dc2eaf11e388b0090a96c732ffad821465b4f79e9fecfd60c0ae8a17b
- response sha256
- 0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
- retrieved at
- 2026-09-09T23:47:23.138359+00:00
- publication date
- display
- 2017 May
- precision
- month
- year
- 2017
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models.
Preserved source evidence · Not medical advice